Obermatt

Getinge

STO:GETI B · SE0000202624
Health Care Equipment & SuppliesMedium

360

63
EV / EBIT77
Price / Owner Earnings36
Owner Earnings Yield60
Dividend Yield73
Price/Sales69
EV / Gross Profit71
Price/Book75
Return on Capital53
Cash Return on Capital44
Return on Equity41
EBIT Margin45
Gross Profitability29
Cash Conversion61
Accruals42
Owner Earnings Margin48
Sales growth21
Profit Growth69
Long-Term EPS Growth53
Owner Earnings Growth61
Reinvestment33
Price momentum79
Debt load61
Refinancing41
Debt Payback33
Liquidity54
Analyst ratings25
Opinion Changes50
Price Target Upside45
Market mood75
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Getinge clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeOM
Founded1990
Employees6,571
ISINSE0000202624
Last UpdateApr 2, 2026
Themes
Health DiagnosticsCardiovascularBiomedical EngineeringSurgeryRespiratoryVaccinesEnterprise SoftwareHealth CareHospitalityMedicalMedical DeviceProfessional Services

Description

Getinge AB (publ) operates as a global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. The company's offerings include equipment for intensive care, cardiovascular proce…

Analysis

Middle-of-the-road

Getinge AB (publ) sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is fair. The owner-earnings multiple stands at 22.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 8% a year, against analyst forecasts of 10%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is adequate. The company scores 12/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
84
2023202420252026

All-time high

93

Jan 2024

All-time low

25

Nov 2024

Average rank

62

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
69
66
68
68
Price/Earnings
68
73
64
67
Price/Book
75
80
82
61
Dividend Yield
73
78
78
74
Value (overall)
91
85
87
93

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Getinge with its peers
AddLife
STO:ALIF B
83
CountrySweden
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Steris
NYQ:STE
63
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Fresenius Medical Care
GER:FME
31
CountryGermany
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Convatec Group
LSE:CTEC
65
CountryUK
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Medartis Holding
SWX:MED
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →